Ethena reported that USDe supply increased by more than $700 million in September. The asset also became Morpho’s second-largest collateral asset overall and its largest collateral asset denominated in dollars, supporting two of the lending protocol’s three markets. The figures were disclosed in Ethena’s official September review, reported by PANews on Oct. 1.